Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06984562 · ClinicalTrials.gov registry record · NA
Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer
A NA study of Locally Advanced Pancreatic Ductal Adenocarcinoma (PDA), sponsored by Fox Chase Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT06984562 is a NA study of Locally Advanced Pancreatic Ductal Adenocarcinoma (PDA) that is actively recruiting participants, run by Fox Chase Cancer Center. The registered enrollment target is 16 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06984562, a NA study of Locally Advanced Pancreatic Ductal Adenocarcinoma (PDA), is actively recruiting participants, sponsored by Fox Chase Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer. The main questions the study aims to answer are: * Can ART improve how well radiation therapy targets the most aggressive cancer cells, while protecting the healthy tissue around the tumor? * Can ART help reduce the side effects that participants may experience during treatment? Participants will: * Undergo CT scans to plan the exact location of the radiation treatment. During this process, 1-3 small markers may be placed in or near the tumor to help with the planning. * Have a tumor biopsy, which involves taking a small sample of tissue from the cancer. * Receive 5 radiation treatments every other day over a 2-week period. * Provide blood samples before, during, and after your radiation treatment.
Conditions Studied
Interventions
- RADIATION Adaptive Radiation Therapy
Study Locations (1)
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2025-08-20 |
| Est. Completion | 2029-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06984562
The ClinicalTrials.gov registry entry for NCT06984562 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Locally Advanced Pancreatic Ductal Adenocarcinoma (PDA) appearing as the primary indexed condition, and to 1 intervention - of which Adaptive Radiation Therapy is the first listed.
NCT06984562 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06984562 about?
NCT06984562 is a clinical study titled "Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer". The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer. The main questions the study aims to answer are: * Can ART improve how well radiation therapy targets the most aggressive cancer cells...
What is the current status of trial NCT06984562?
This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2025-08-20. Estimated completion is 2029-08-01.
What conditions does trial NCT06984562 study?
This clinical trial studies the following conditions: Locally Advanced Pancreatic Ductal Adenocarcinoma (PDA).
What interventions are being tested in trial NCT06984562?
The interventions under investigation include: Adaptive Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT06984562?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06984562 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.